Ads

 

Ads

 

Ads

 

World Top 100 Healthcare Companies List by Market Cap as of August 2026

World Top 100 Healthcare Companies List by Market Cap as of August 2026, World Biggest 100 Healthcare Companies by Market Cap, World Largest 100 Healthcare Companies in the World by market cap as of August 2026.

Metatag Title
World Top Healthcare Companies in 2026
Metatag Abstract
World Top Healthcare Companies by Market Cap in 2026, World Top Healthcare Companies by Market Cap in 2026.
  1. Tsumura & Co

    World Rank (Aug-2026)
    6,826
    Market Cap (Aug-2026)
    1.764 Billion USD
    World Rank (Jan-05-2024)
    7,056
    Market Cap (Jan-05-2024)
    1.406 Billion USD
    World Rank (Jul-30-2023)
    7,117
    Market Cap (Jul-30-2023)
    1.422 Billion USD
    World Rank (Dec-25-2022)
    6,053
    Market Cap (Dec-25-2022)
    1.688 Billion USD
    World Rank (Jan-07-2022)
    5,934
    Market Cap (Jan-07-2022)
    2.18 Billion USD
    Annual Revenue in USD
    945 Million USD
    Annual Net Income in USD
    137 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    TSUMURA & CO is a Pharmaceutical company focused on Raw Materials for Crude Drug. The company annual revenue is 130,881 million JPY and annual net income is 15,332 million JPY as on 2021. The headquarters is in Japan.
  2. Skan Group AG

    World Rank (Aug-2026)
    6,835
    Market Cap (Aug-2026)
    1.760 Billion USD
    World Rank (Jan-05-2024)
    5,502
    Market Cap (Jan-05-2024)
    2.106 Billion USD
    World Rank (Jul-30-2023)
    5,658
    Market Cap (Jul-30-2023)
    2.042 Billion USD
    World Rank (Dec-25-2022)
    6,373
    Market Cap (Dec-25-2022)
    1.571 Billion USD
    Headquarters Country
    Company Profile

    SKAN manufacture healthcare industry needed equipment like isolators, clean room devices and decontamination processes for the aseptic production of biopharmaceutical active ingredients. SKAN's core competency is the development and construction of process isolators for the aseptic filling of biopharmaceutical products. Headquarters is in Switzerland.

  3. ANI Pharmaceuticals Inc.

    World Rank (Aug-2026)
    6,839
    Market Cap (Aug-2026)
    1.757 Billion USD
    World Rank (Jan-05-2024)
    7,914
    Market Cap (Jan-05-2024)
    1.149 Billion USD
    World Rank (Jul-30-2023)
    8,477
    Market Cap (Jul-30-2023)
    1.055 Billion USD
    World Rank (Dec-25-2022)
    10,448
    Market Cap (Dec-25-2022)
    0.689 Billion USD
    World Rank (Jan-07-2022)
    11,253
    Market Cap (Jan-07-2022)
    0.73 Billion USD
    Annual Revenue in USD
    883 Million USD
    Annual Operating Income in USD
    111 Million USD
    Annual Net Income in USD
    78 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    ANI Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is focused on delivering value to customers by developing, manufacturing and marketing high quality branded and generic prescription pharmaceuticals. The company annual revenue is 206.5 million USD and 338 employees as on 2019. The headquarters is in USA.
  4. Xencor

    World Rank (Aug-2026)
    6,884
    Market Cap (Aug-2026)
    1.735 Billion USD
    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    126 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -92 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
  5. AnaptysBio Inc.

    World Rank (Aug-2026)
    6,897
    Market Cap (Aug-2026)
    1.731 Billion USD
    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    235 Million USD
    Annual Operating Income in USD
    48 Million USD
    Annual Net Income in USD
    -13 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
  6. Biotest

    World Rank (Aug-2026)
    6,900
    Market Cap (Aug-2026)
    1.729 Billion USD
    World Rank (Jan-05-2024)
    6,541
    Market Cap (Jan-05-2024)
    1.590 Billion USD
    World Rank (Jul-30-2023)
    6,536
    Market Cap (Jul-30-2023)
    1.623 Billion USD
    World Rank (Dec-25-2022)
    6,266
    Market Cap (Dec-25-2022)
    1.607 Billion USD
    World Rank (Jan-07-2022)
    6,569
    Market Cap (Jan-07-2022)
    1.87 Billion USD
    Annual Revenue in USD
    569 Million USD
    Annual Operating Income in USD
    -9 Million USD
    Annual Net Income in USD
    -35 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine company develops, manufactures and markets plasma proteins and biotherapeutic drugs. It is having more than 1,900 employees. The company annual revenue is 484.2 million EUR and total assets are 1,131.3 million EUR as on 2020. The headquarters is in Germany.
  7. Nakanishi

    World Rank (Aug-2026)
    6,923
    Market Cap (Aug-2026)
    1.718 Billion USD
    World Rank (Jan-05-2024)
    6,996
    Market Cap (Jan-05-2024)
    1.422 Billion USD
    World Rank (Jul-30-2023)
    5,873
    Market Cap (Jul-30-2023)
    1.939 Billion USD
    World Rank (Dec-25-2022)
    6,206
    Market Cap (Dec-25-2022)
    1.628 Billion USD
    World Rank (Jan-07-2022)
    7,061
    Market Cap (Jan-07-2022)
    1.65 Billion USD
    Annual Revenue in USD
    327 Million USD
    Annual Net Income in USD
    74 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Nakanishi manufactures and sells dental products, surgical products and general industrial products company. The company annual revenue is 44,857 million JPY and annual net income is 10,102 million JPY as on 2021. The headquarters is in Japan.
  8. BioLife Solutions Inc.

    World Rank (Aug-2026)
    6,929
    Market Cap (Aug-2026)
    1.715 Billion USD
    World Rank (Jan-05-2024)
    10,505
    Market Cap (Jan-05-2024)
    0.707 Billion USD
    World Rank (Jul-30-2023)
    9,534
    Market Cap (Jul-30-2023)
    0.858 Billion USD
    World Rank (Dec-25-2022)
    9,928
    Market Cap (Dec-25-2022)
    0.755 Billion USD
    World Rank (Jan-07-2022)
    8,152
    Market Cap (Jan-07-2022)
    1.28 Billion USD
    Annual Revenue in USD
    96 Million USD
    Annual Operating Income in USD
    -17 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile
    BioLife Solutions is a supplier of class defining cell and Gene Therapy Bioproduction tools and services company. The headquarters is in USA.
    Facts About Company
    BioLife Solutions company annual revenue was 161 million USD and annual net loss was -139 as on 2019.
  9. Shenzhen Hepalink Pharmaceutical Group

    World Rank (Aug-2026)
    6,932
    Market Cap (Aug-2026)
    1.714 Billion USD
    World Rank (Jan-05-2024)
    5,488
    Market Cap (Jan-05-2024)
    2.119 Billion USD
    World Rank (Jul-30-2023)
    5,364
    Market Cap (Jul-30-2023)
    2.220 Billion USD
    World Rank (Dec-25-2022)
    4,757
    Market Cap (Dec-25-2022)
    2.425 Billion USD
    World Rank (Jan-07-2022)
    4,344
    Market Cap (Jan-07-2022)
    3.50 Billion USD
    Annual Revenue in USD
    926 Million USD
    Annual Net Income in USD
    35 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  10. Omnicell

    World Rank (Aug-2026)
    6,957
    Market Cap (Aug-2026)
    1.701 Billion USD
    World Rank (Jan-05-2024)
    6,640
    Market Cap (Jan-05-2024)
    1.551 Billion USD
    World Rank (Jul-30-2023)
    4,544
    Market Cap (Jul-30-2023)
    2.838 Billion USD
    World Rank (Dec-25-2022)
    5,174
    Market Cap (Dec-25-2022)
    2.163 Billion USD
    World Rank (Jan-07-2022)
    2,484
    Market Cap (Jan-07-2022)
    7.13 Billion USD
    Annual Revenue in USD
    1,185 Million USD
    Annual Operating Income in USD
    5 Million USD
    Annual Net Income in USD
    2 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Omnicell is an Autonomous Pharmacy Management Systems and Solutions developing software company. It provides workflow automation, data intelligence and technology enabled services that allow caregivers everywhere to focus on improving patient outcomes. The headquarters is in USA.

Share

Ads